SPYRE THERAPEUTICS INC

Ticker: SYRE CUSIP: 00773J202 Class: Common Stock

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,659,140 Value ($000) $54,362 Avg Close $26.13 Range $15.86 - $35.31
Q3 2025
Shares 1,225,153 Value ($000) $20,536 Avg Close $16.31 Range $14.00 - $18.30
Q2 2025
Shares 1,227,232 Value ($000) $18,373 Avg Close $14.80 Range $10.91 - $19.20
Q1 2025
Shares 1,059,563 Value ($000) $17,100 Avg Close $20.81 Range $16.13 - $26.01
Q4 2024
Shares 966,129 Value ($000) $22,498 Avg Close $29.32 Range $22.37 - $40.26
Q3 2024
Shares 891,048 Value ($000) $26,211 Avg Close $27.85 Range $23.00 - $32.41
Q2 2024
Shares 765,834 Value ($000) $18,008 Avg Close $33.73 Range $22.19 - $40.84
Q1 2024
Shares 330,225 Value ($000) $12,529 Avg Close $28.97 Range $18.54 - $47.97
Q4 2023
Shares 30,326 Value ($000) $653 Avg Close $13.78 Range $8.43 - $22.66
Q3 2023
Shares 26,800 Value ($000) $328 Avg Close $13.22 Range $9.53 - $18.00